Jane Street’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.1M Buy
61,800
+36,300
+142% +$7.82M ﹤0.01% 2221
2025
Q4
$5.24M Buy
25,500
+6,900
+37% +$1.3M ﹤0.01% 3154
2025
Q3
$2.92M Sell
18,600
-171,200
-90% -$26.4M ﹤0.01% 4270
2025
Q2
$31.9M Sell
189,800
-114,600
-38% -$17M 0.01% 1053
2025
Q1
$41.9M Buy
304,400
+189,100
+164% +$24.1M 0.01% 764
2024
Q4
$13.6M Buy
115,300
+89,900
+354% +$10.5M ﹤0.01% 1607
2024
Q3
$2.81M Buy
25,400
+19,900
+362% +$2.08M ﹤0.01% 3850
2024
Q2
$541K Sell
5,500
-50,700
-90% -$5.17M ﹤0.01% 6894
2024
Q1
$6.29M Buy
56,200
+25,400
+82% +$2.74M ﹤0.01% 2320
2023
Q4
$3.1M Buy
30,800
+21,900
+246% +$2.17M ﹤0.01% 3584
2023
Q3
$773K Sell
8,900
-6,600
-43% -$597K ﹤0.01% 5561
2023
Q2
$1.47M Sell
15,500
-43,700
-74% -$3.69M ﹤0.01% 4627
2023
Q1
$4.47M Sell
59,200
-17,500
-23% -$1.32M ﹤0.01% 2603
2022
Q4
$5.9M Sell
76,700
-98,500
-56% -$7.48M ﹤0.01% 2262
2022
Q3
$11.7M Buy
175,200
+42,900
+32% +$2.72M 0.01% 1545
2022
Q2
$6.92M Buy
132,300
+65,700
+99% +$3.73M ﹤0.01% 2195
2022
Q1
$3.78M Sell
66,600
-59,600
-47% -$3.19M ﹤0.01% 3514
2021
Q4
$6.5M Sell
126,200
-8,700
-6% -$427K ﹤0.01% 2456
2021
Q3
$6.67M Buy
134,900
+64,200
+91% +$3.48M ﹤0.01% 2333
2021
Q2
$4.04M Buy
70,700
+17,100
+32% +$999K ﹤0.01% 3025
2021
Q1
$3.26M Sell
53,600
-7,000
-12% -$386K ﹤0.01% 3094
2020
Q4
$3.25M Buy
60,600
+4,300
+8% +$223K ﹤0.01% 2719
2020
Q3
$2.64M Sell
56,300
-2,300
-4% -$118K ﹤0.01% 2611
2020
Q2
$3.06M Buy
58,600
+24,700
+73% +$1.27M ﹤0.01% 2476
2020
Q1
$1.63M Sell
33,900
-4,000
-11% -$208K ﹤0.01% 2233
2019
Q4
$1.92M Buy
37,900
+30,200
+392% +$1.56M ﹤0.01% 1989
2019
Q3
$363K Sell
7,700
-1,900
-20% -$86.7K ﹤0.01% 3939
2019
Q2
$452K Sell
9,600
-8,100
-46% -$374K ﹤0.01% 3709
2019
Q1
$852K Sell
17,700
-8,100
-31% -$406K ﹤0.01% 3011
2018
Q4
$1.15M Buy
25,800
+14,700
+132% +$766K ﹤0.01% 2363
2018
Q3
$599K Sell
11,100
-900
-8% -$46.1K ﹤0.01% 3397
2018
Q2
$586K Sell
12,000
-11,200
-48% -$635K ﹤0.01% 3419
2018
Q1
$1.45M Buy
23,200
+4,900
+27% +$336K ﹤0.01% 2223
2017
Q4
$1.12M Sell
18,300
-2,700
-13% -$167K ﹤0.01% 2211
2017
Q3
$1.41M Buy
21,000
+17,000
+425% +$1.2M ﹤0.01% 1942
2017
Q2
$312K Buy
+4,000
New +$302K ﹤0.01% 3559
2017
Q1
Sell
-8,400
Closed -$605K 4149
2016
Q4
$605K Buy
8,400
+2,500
+42% +$181K ﹤0.01% 2638
2016
Q3
$458K Sell
5,900
-9,900
-63% -$800K ﹤0.01% 2858
2016
Q2
$1.23M Buy
15,800
+13,100
+485% +$1.04M 0.01% 1750
2016
Q1
$221K Buy
+2,700
New +$220K ﹤0.01% 3582

Other funds holding CAH

Jane Street's CAH Position: Q1 2026 in Review

Jane Street reduced its Cardinal Health (CAH) stake by 96% in Q1 2026, selling an estimated $93.4M and leaving 18,369 shares worth $3.88M. The position accounts for ﹤0.01% of the portfolio, ranked #3910.

Jane Street first reported a position in CAH in Q4 2013 and has held it in 46 quarters since. The position peaked at $92.9M in Q4 2025. 1,424 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Jane Street held 18,369 shares of Cardinal Health worth $3.88M as of Q1 2026.
  • Jane Street sold 433,810 Cardinal Health shares in Q1 2026, an estimated $93.4M.
  • Cardinal Health made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #3910 holding.
  • Jane Street first reported a position in Cardinal Health in Q4 2013 and has held it in 46 quarters since.
  • Jane Street's Cardinal Health position peaked at $92.9M in Q4 2025.
  • 1,424 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.